PTC Therapeutics Inc (NASDAQ:PTCT)

55.21
Delayed Data
As of May 21
 +1.27 / +2.35%
Today’s Change
14.51
Today|||52-Week Range
78.72
+6.64%
Year-to-Date
No recent news for PTC Therapeutics Inc.

Today’s Trading

Previous close53.94
Today’s open54.00
Day’s range-- - --
Volume961,577
Average volume (3 months)824,839
Market cap$1.8B
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)+42.66%
Earnings growth (this year)-52.22%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.24%
P/E ratioNM
Price/Sales--
Price/Book5.95

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+0.18+0.37%
MDCOMedicines Co+0.25+0.92%
ADROAduro Biotech Inc+1.60+5.36%
SAGESAGE Therapeutics In...+5.29+8.40%
Data as of 05/21/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$25.2M
Annual profit (last year)-$93.8M
Net profit margin-371.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Executive VP-Research, Operations &
Technology
Neil Gregory Almstead
Corporate headquarters
South Plainfield, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers